The dynamics of technological innovation: the case of the pharmaceutical industry

By B. Achilladelis, N. Antonakis. 2001

193 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Evaluating firm technological innovation capability under uncertainty (2008, background): “, 1998), success rate of R&D products (proposed by this study), self-generated innovative products (proposed by this study), number of patents (OEDC, 1992/1996; Achilladelis and Antonajis, 2001; Damanpour and Wischnevsky, 2006), and R&D intensity (Sterlacchini, 1996; Manu and Sriram, 1996; OEDC, 199”
Entrepreneurship in the large corporation: a longitudinal study of how established firms create breakthrough inventions (2001, background): “Inventions that serve as the source of many subsequent inventions can be regarded as breakthrough or radical because they have demonstrated their utility on the path of technological progress (Achilladelis et al., 1990; Fleming, 1999).”
Effects of organizational innovation and technological innovation capabilities on firm performance: evidence from firms in China’s Pearl River Delta (2019, methodology): “A substantial body of literature on technological innovation studies suggests that conceptions of TICs are complex and multidimensionally conceptual (Achilladelis and Antonakis 2001; Markard and Truffer 2008; Wang, Lu, and Chen 2008; Yam et al. 2011).”